Gene · 3925
Papers4,446
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,446
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of novel long non-coding RNA involved in Sertoli cell of non-obstructive azoospermia based on microarray and bioinformatics analysis. | Genomics | 2025 | 40280502 | PubTator, text mining | PubMed |
| Colorectal cancer stem cells develop NK cell resistance via homotypic cell-in-cell structures suppressed by Stathmin1. | Theranostics | 2025 | 40225568 | PubTator, text mining | PubMed |
| The Stmn1-lineage contributes to acinar regeneration but not to neoplasia upon oncogenic Kras expression. | bioRxiv | 2025 | 40166191 | PubTator, text mining | PubMed |
| Stathmin 1 regulates mitophagy and cellular function in hematopoietic stem cells. | bioRxiv | 2025 | 40161782 | PubTator, text mining | PubMed |
| Association of Stmn1 Polymorphism and Cognitive Function: An Observational Study in the Chinese Adults. | Alpha Psychiatry | 2025 | 40110371 | PubTator, text mining | PubMed |
| Immune-featured stromal niches associate with response to neoadjuvant immunotherapy in oral squamous cell carcinoma. | Cell Rep Med | 2025 | 40107247 | PubTator, text mining | PubMed |
| Prognostic role of STMN1 expression and neoadjuvant therapy efficacy in breast cancer. | BMC Cancer | 2025 | 40082837 | PubTator, text mining | PubMed |
| TGFβ-activated Asporin interacts with STMN1 to promote prostate cancer docetaxel chemoresistance and metastasis by upregulating the Wnt/β-catenin signaling pathway. | Drug Resist Updat | 2025 | 40073743 | PubTator, text mining | PubMed |
| Eribulin exerts multitarget antineoplastic activity in glioma cells. | Pharmacol Rep | 2025 | 40056292 | PubTator, text mining | PubMed |
| Characterisation and comparative analysis of mitochondrial genomes of false, yellow, black and blushing morels provide insights on their structure and evolution. | IMA Fungus | 2025 | 40052075 | PubTator, text mining | PubMed |
| miRNA-1229-5p promotes migration and invasion and suppresses apoptosis of endometrial cells via the STMN1/p38 MAPK axis in endometriosis. | Gene | 2025 | 40037422 | PubTator, text mining | PubMed |
| circFOXK2 Stabilizes STMN1 mRNA via PABPC1 to Promote the Progression of NSCLC. | Cancer Med | 2025 | 40013670 | PubTator, text mining | PubMed |
| Revealing the core suppression effects of various Di (2-ethylhexyl) phthalate exposure on early meiosis progression in postnatal male mice via single-cell RNA sequencing. | Ecotoxicol Environ Saf | 2025 | 39923572 | PubTator, text mining | PubMed |
| RNF31 induces paclitaxel resistance by sustaining ALYREF cytoplasmic-nuclear shuttling in human triple-negative breast cancer. | Clin Transl Med | 2025 | 39915011 | PubTator, text mining | PubMed |
| Highly Stable Antitumor Silver-Lipid Nanoparticles Optimized for Targeted Therapy. | Int J Nanomedicine | 2025 | 39911260 | PubTator, text mining | PubMed |
| Innovative logic "AND" gate gene circuits for bladder cancer treatment: preclinical study. | Int J Surg | 2025 | 39903549 | PubTator, text mining | PubMed |
| Exploring proteomic immunoprofiles: common neurological and immunological pathways in multiple sclerosis and type 1 diabetes mellitus. | Mol Med | 2025 | 39901093 | PubTator, text mining | PubMed |
| Epithelial cell diversity and immune remodeling in bladder cancer progression: insights from single-cell transcriptomics. | J Transl Med | 2025 | 39885578 | PubTator, text mining | PubMed |
| Identification of novel cytoskeleton protein involved in spermatogenic cells and sertoli cells of non-obstructive azoospermia based on microarray and bioinformatics analysis. | BMC Med Genomics | 2025 | 39863862 | PubTator, text mining | PubMed |
| Single-cell profiling transcriptomic reveals cellular heterogeneity and cellular crosstalk in breast cancer lymphatic node, bone, and brain metastases. | Sci Rep | 2025 | 39820531 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3925/papers?page=7